The reduction in flow at the level of the small airways (FEF 25–75% ) also demonstrated an improvement, although it did not reach statistical significance either at T12 or T24.
← all excerpts
Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study.
1
—
—